Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Lung cancer screening-don't forget the chest radiograph.

Gossner J.

World J Radiol. 2014 Apr 28;6(4):116-8. doi: 10.4329/wjr.v6.i4.116. Review.

2.

Is it useful to combine sputum cytology and low-dose spiral computed tomography for early detection of lung cancer in formerly asbestos-exposed power industry workers?

Felten MK, Knoll L, Schikowsky C, Das M, Feldhaus C, Hering KG, Böcking A, Kraus T.

J Occup Med Toxicol. 2014 Apr 17;9:14. doi: 10.1186/1745-6673-9-14. eCollection 2014.

3.

Oxidative stress and exhaled breath analysis: a promising tool for detection of lung cancer.

Chan HP, Lewis C, Thomas PS.

Cancers (Basel). 2010 Feb 8;2(1):32-42. doi: 10.3390/cancers2010032.

4.

Interpreting secondary cardiac disease variants in an exome cohort.

Ng D, Johnston JJ, Teer JK, Singh LN, Peller LC, Wynter JS, Lewis KL, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program.

Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. doi: 10.1161/CIRCGENETICS.113.000039. Epub 2013 Jul 16.

5.

Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model.

Bell RC, Rogith D, Johnson CW, Badea CT, Athreya KK, Espinosa G, Clark D, Ghafoori AP, Li Y, Kirsch DG, Annapragada A, Ghaghada K.

AMIA Annu Symp Proc. 2012;2012:27-35. Epub 2012 Nov 3.

6.

Reader variability in identifying pulmonary nodules on chest radiographs from the national lung screening trial.

Singh SP, Gierada DS, Pinsky P, Sanders C, Fineberg N, Sun Y, Lynch D, Nath H.

J Thorac Imaging. 2012 Jul;27(4):249-54. doi: 10.1097/RTI.0b013e318256951e.

7.

Cancer screening: the journey from epidemiology to policy.

Deppen SA, Aldrich MC, Hartge P, Berg CD, Colditz GA, Petitti DB, Hiatt RA.

Ann Epidemiol. 2012 Jun;22(6):439-45. doi: 10.1016/j.annepidem.2012.03.004.

8.

Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.

9.

Circulating microRNAs: next-generation biomarkers for early lung cancer detection.

Bianchi F, Nicassio F, Veronesi G, di Fiore PP.

Ecancermedicalscience. 2012;6:246. doi: 10.3332/ecancer.2012.246. Epub 2012 Mar 6.

10.

Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.

Richards KL, Zhang B, Sun M, Dong W, Churchill J, Bachinski LL, Wilson CD, Baggerly KA, Yin G, Hayes DN, Wistuba II, Krahe R.

Cancer. 2011 Feb 1;117(3):606-17. doi: 10.1002/cncr.25472. Epub 2010 Oct 13.

11.

Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer.

Spivey KA, Banyard J, Solis LM, Wistuba II, Barletta JA, Gandhi L, Feldman HA, Rodig SJ, Chirieac LR, Zetter BR.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1362-72. doi: 10.1158/1055-9965.EPI-09-1095.

12.

Identification of lung cancer with high sensitivity and specificity by blood testing.

Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, Andres C, Staratschek-Jox A, Wolf J, Stoelben E, Stephan B, Stehle I, Hamacher J, Huwer H, Lenhof HP, Meese E.

Respir Res. 2010 Feb 10;11:18. doi: 10.1186/1465-9921-11-18.

13.

Modeling excess lung cancer risk among screened arm participants in the Mayo Lung Project.

Goldwasser DL, Kimmel M.

Cancer. 2010 Jan 1;116(1):122-31. doi: 10.1002/cncr.24722.

14.

The use of genetic markers to identify lung cancer in fine needle aspiration samples.

Gill RK, Vazquez MF, Kramer A, Hames M, Zhang L, Heselmeyer-Haddad K, Ried T, Shilo K, Henschke C, Yankelevitz D, Jen J.

Clin Cancer Res. 2008 Nov 15;14(22):7481-7. doi: 10.1158/1078-0432.CCR-07-5242.

15.

Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.

McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.

Cancer. 2008 Dec 15;113(12):3440-9. doi: 10.1002/cncr.23962.

16.

Lung cancer metastasis to the scapula and spine: a case report.

Demetrious J, Demetrious GJ.

Chiropr Osteopat. 2008 Aug 12;16:8. doi: 10.1186/1746-1340-16-8.

17.

Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS.

Radiology. 2008 Jul;248(1):278-87. doi: 10.1148/radiol.2481071446. Epub 2008 May 5.

18.

The LLP risk model: an individual risk prediction model for lung cancer.

Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK.

Br J Cancer. 2008 Jan 29;98(2):270-6. Epub 2007 Dec 18.

19.

Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature.

Black C, de Verteuil R, Walker S, Ayres J, Boland A, Bagust A, Waugh N.

Thorax. 2007 Feb;62(2):131-8. Review.

20.

Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.

Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH.

Am J Respir Crit Care Med. 2007 Apr 1;175(7):712-9. Epub 2006 Dec 21.

Supplemental Content

Support Center